Apoquel Chewable is a drug owned by ZOETIS INC. It is protected by 4 US drug patents filed from 2030 to 2041. All patents are active. Details of Apoquel Chewable’s patents and their expiration are given below.
About Apoquel Chewable
Apoquel Chewable is a drug
owned by ZOETIS INC.
Apoquel Chewable uses
Oclacitinib as the active
ingredient.
Active Ingredient:
Apoquel Chewable uses
Oclacitinib as the active ingredient.
Check out other Drugs and Companies using
Oclacitinib ingredient.